News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
EXACT Sciences Corporation Reports Third-Quarter 2009 Financial Results
November 3, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the third quarter ended Sept. 30, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Lung cancer
AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B
July 14, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
FDA proposes streamlined requirements for ‘hub-and-spoke’ manufacturing models
July 14, 2026
·
2 min read
·
Nick Paul Taylor
Layoff Tracker
EMD Serono may trim R&D workforce by up to 70
July 13, 2026
·
68 min read
·
BioSpace Editorial Staff
Immunology and inflammation
AB Science ends 3 studies in multiple sclerosis, other immune conditions
July 13, 2026
·
2 min read
·
Tristan Manalac
